Novartis AG plans to buy back $5 billion of stock over two years and said it will expand in faster-growing areas of health care such as treatments... ...http://www.business-standard.com/article/international/novartis-sets-5-bn-buyback-adds-business-segments-113112300022_1.html
Leukemia drug was found to reverse symptoms of colitis in lab tests, say University of Alberta scientists. Faculty of Medicine & Dentistry... ...http://www.medindia.net/news/potential-new-treatment-for-colitis-discovered-126939-1.htm
Novartis International AG / . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this... ...http://andhranews.net/Business/2013/Novartis-delivers-strong-sales-performance-third-43308.htm
SEATTLE, Oct. 14, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today announced the addition of three leaders in the... ...http://in.sys-con.com/node/2831771
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=78060&sid=2
For Buying Imatinib & Gleevec Online...